Treatment to boost white blood cells may benefit patients with glioblastoma


A new study led by Washington University School of Medicine in St. Louis reveals at least one cause of low white blood cell counts in patients treated for glioblastoma and demonstrates a potential treatment strategy that improves survival in mice.

Activated neutrophils can become potent cancer fighters

Previous article

Biology underlying pair bonding and parenting may not be dictated by oxytocin receptors, study shows

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News